five hundred and eighty-five patients with threatened stroke were followed in a randomized clinical trial for an average of 26 months to determine whether aspirin or sulfinpyrazone , singly or in combination , influence the subsequent occurrence of continuing transient ischemic attacks , stroke or death .
C0007787
transient ischemic attacks
C0038454
stroke